2021 Q3 Form 10-Q Financial Statement
#000109181821000140 Filed on October 28, 2021
Income Statement
Concept | 2021 Q3 | 2020 Q3 | 2020 Q2 |
---|---|---|---|
Revenue | |||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $20.02K | $3.300K | $3.300K |
YoY Change | 506.79% | ||
Operating Profit | -$20.02K | -$3.300K | |
YoY Change | |||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | |||
YoY Change | |||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$20.02K | -$3.300K | -$3.300K |
YoY Change | 506.79% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | |||
COMMON SHARES | |||
Basic Shares Outstanding | 47.23M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q3 | 2020 Q3 | 2020 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $1.700K | $1.700K | $1.700K |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | |||
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | |||
YoY Change | |||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | |||
Total Long-Term Liabilities | |||
Total Liabilities | |||
YoY Change | |||
SHAREHOLDERS EQUITY | |||
Retained Earnings | |||
YoY Change | |||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$5.400K | -$99.20K | -$96.20K |
YoY Change | |||
Total Liabilities & Shareholders Equity | |||
YoY Change |
Cashflow Statement
Concept | 2021 Q3 | 2020 Q3 | 2020 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$20.02K | -$3.300K | -$3.300K |
YoY Change | 506.79% | ||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | |||
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | |||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | |||
Cash From Investing Activities | |||
Cash From Financing Activities | |||
Net Change In Cash | |||
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | |||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000894501 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
75087284 | shares | |
us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
30000 | USD | |
us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
30000 | USD | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
47227500 | shares | |
CY2021Q3 | grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
3000 | USD |
CY2020Q3 | grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
3000 | USD |
CY2021Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | ||
CY2021Q3 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
USD | |
CY2020Q3 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
USD | |
grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
9000 | USD | |
grhi |
Consulting Fees Expenses
ConsultingFeesExpenses
|
9000 | USD | |
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
17024 | USD |
CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
300 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
41927 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
900 | USD | |
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
20024 | USD |
CY2020Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
3300 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
80927 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
39900 | USD | |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20024 | USD |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3300 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-80927 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-39900 | USD | |
CY2021Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
87290368 | shares |
CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
47227500 | shares |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
3100 | USD | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
USD | ||
grhi |
Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
|
3000 | USD | |
grhi |
Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
|
USD | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
38627 | USD | |
grhi |
Common Shares Issued For Consulting1
CommonSharesIssuedForConsulting1
|
29000 | USD | |
grhi |
Common Shares Issued For Consulting1
CommonSharesIssuedForConsulting1
|
USD | ||
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
-100 | USD | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
USD | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
6100 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
8600 | USD | |
grhi |
Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
|
-1000 | USD | |
grhi |
Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
|
-30000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-38627 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1300 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | ||
us-gaap |
Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
|
38627 | USD | |
us-gaap |
Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
|
1300 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1300 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
USD | ||
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1700 | USD |
us-gaap |
Interest Paid
InterestPaid
|
USD | ||
us-gaap |
Interest Paid
InterestPaid
|
USD | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
USD | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
USD | ||
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-60600 | USD |
grhi |
Capital Contributions Director
CapitalContributionsDirector
|
1300 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-39900 | USD | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-99200 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102200 | USD |
grhi |
Stock Issued During Period Value For Accrued Expenses Directors Fees
StockIssuedDuringPeriodValueForAccruedExpensesDirectorsFees
|
104000 | USD | |
grhi |
Stock Issued During Period Value For Consulting And Director Compensation
StockIssuedDuringPeriodValueForConsultingAndDirectorCompensation
|
32000 | USD | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
3100 | USD | |
grhi |
Capital Contributions Director
CapitalContributionsDirector
|
38627 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-80927 | USD | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5400 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-96200 | USD |
CY2020Q3 | grhi |
Capital Contributions Director
CapitalContributionsDirector
|
300 | USD |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3300 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-99200 | USD |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9254 | USD |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
3100 | USD |
CY2021Q3 | grhi |
Capital Contributions Director
CapitalContributionsDirector
|
20778 | USD |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20024 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5400 | USD |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p> | ||
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
38627 | USD | |
us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
1300 | USD | |
grhi |
Increase Decrease In Additional Paid In Capital
IncreaseDecreaseInAdditionalPaidInCapital
|
38627 | USD | |
grhi |
Increase Decrease In Additional Paid In Capital
IncreaseDecreaseInAdditionalPaidInCapital
|
1300 | USD | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
850000000 | shares |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47227500 | shares |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47227500 | shares |